Search

everythinglearnresearchcommunity

for

Search:↓

After a year of using finasteride, topical minoxidil, Nizoral shampoo, and derma stamping, the user experienced significant hair regrowth and increased hair density, despite an initial shedding phase. The user attributes the success to consistency and patience, noting that derma stamping significantly boosted regrowth speed and quality.

The user claims significant hair regrowth using 2.5mg Minoxidil and 1mg Finasteride over three months, but others question the validity due to differences in hair styling between photos. The user reports no side effects except for body hair growth.

A 21-year-old shared their 6-month hair regrowth journey using daily finasteride tablets and once-daily topical minoxidil, noting significant improvement in hair thickness, especially at the corners, with minimal side effects. They also mentioned using minoxidil for beard growth with limited success and occasionally using a dermaroller.

Finasteride can cause initial hair shedding as part of the treatment process, which is normal and often leads to regrowth of healthier hair. Users discuss experiencing multiple shedding phases and emphasize patience, as results can take several months to become noticeable.

Hair transplantation involves a detailed consultation, preparation, and a long-term recovery process with stages like initial shedding and gradual new hair growth over months. Setting realistic expectations is crucial for patient satisfaction.

PP405 may help with hair regrowth, especially when combined with minoxidil and finasteride, but its long-term effectiveness is unclear. Phase 3 trials are expected to begin soon, with results in a few years.

The conversation discusses hair shedding experienced by users on minoxidil and finasteride treatments, with some considering additional options like spironolactone and dutasteride. Many users report experiencing a second shedding phase but are advised to continue treatment as it may lead to thicker hair regrowth.

A user shared their positive experience with a crown MicroFUE hair transplant at Boston Hair Restoration, highlighting the smooth procedure, minimal pain, and significant growth over 12 months. They used oral minoxidil, finasteride (transitioning to dutasteride), PRP sessions, and a LaserCap, achieving excellent results and full confidence.

A user shared progress after 5 months on oral finasteride (1mg) and minoxidil (2.5mg), noting improvements despite minimal temple growth. They experienced shedding initially but reported no side effects, and others shared similar experiences and additional treatments like hair serums.

A user shared their hair regrowth progress using oral finasteride, biotin, topical minoxidil, and DS thickening shampoo over five months, reporting significant improvements in hair texture and growth. They experienced minor side effects like a slight headache from switching minoxidil forms but noted no issues with finasteride.

Switching from topical to oral minoxidil can cause initial hair shedding but may lead to thicker hair growth. Many users combine it with finasteride, experiencing varying side effects.

A new hair loss treatment, PP405, showed promising Phase 2a results with 31% of patients experiencing over 20% hair density increase without systemic absorption, avoiding hormonal side effects. The treatment is expected to be expensive, with Phase 3 trials starting mid-2026, and there is skepticism about the data's strength.

A 50-year-old male has been using 0.5mg oral finasteride, 5% topical minoxidil, and weekly microneedling to combat hair loss, seeing progress with new hair growth. He plans to continue this regimen and evaluate results after 12 months.

The user started using EssenGen 6-Plus, containing 6% minoxidil and 0.05% finasteride, along with 1% Nizoral shampoo, and reported noticeable hair growth in 7 weeks. They experienced some chest tightness but are monitoring it, and they are satisfied with the progress despite using a silicone-containing shampoo.

The user has been using minoxidil, finasteride, dermastamping, and Nizoral for hair loss with initial success but is considering adding PRP due to slowed progress. Concerns about PRP include potential ineffectiveness and whether it could harm existing hair growth or interfere with current treatments.

The user experienced hair regrowth using a topical solution containing 5% minoxidil and 0.1% finasteride, despite an initial shedding phase. They reported no side effects and noted significant improvement in hair density, particularly around the crown area.

Sodium dodecyl sulfate, oleic acid, and palmitoleic acid may promote hair growth, but their safety and effectiveness for humans are uncertain. Users consider trying these treatments cautiously, exploring alternatives like ostrich oil and microneedling.

Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.

Pelage Pharmaceutical raised $120 million to continue research on PP405, a promising hair loss treatment that showed a 20% increase in hair density in 31% of men during a Phase 2a trial. The treatment was well-tolerated, with no systemic absorption, and Phase 3 trials are planned for 2026.

A 23-year-old male shared his 11-month progress using 1.25mg finasteride every other day and Nizoral/Dermazole, reporting reduced hair fall and new hair growth without major shedding. Users discussed the risks of finasteride for younger individuals and suggested consulting a doctor, with some recommending minoxidil as an alternative.

The user experienced hair regrowth after 5 months on 5 mg oral minoxidil and 1 mg dutasteride, following a year of ineffective finasteride use. They noticed progress after an initial shedding phase and hope for further improvement, with expectations of near-max regrowth around 18 months.

The conversation discusses the safety study of PP405, emphasizing that early trials focus on safety rather than efficacy, and that any efficacy data from such a short study should be viewed skeptically. It also highlights that the information released is primarily for securing funding, and that meaningful efficacy results are expected in later phases.

The user is experiencing increased hair loss 9 months into a treatment with topical finasteride and minoxidil, along with supplements, and is questioning if this is a temporary phase or if the treatment is ineffective. Opinions vary, with some suggesting shedding is normal, while others debate the effectiveness of topical treatments and the impact of supplements.

The user experienced significant hair regrowth and healthier hair after two months of using oral finasteride, minoxidil, and biotin, despite an initial shedding phase. They reported no negative effects on their beard or facial bloating and were surprised by the quick results.

The user experienced significant hair regrowth after using finasteride, minoxidil, and derma stamping, despite an initial heavy shedding phase. They also take omega-3, zinc, biotin, and folic acid daily, and report improved confidence and hair strength.

Dutasteride can cause hair shedding even with suppressed testosterone levels due to previous damage from DHT. Hair shedding is often a sign of damaged hair being replaced by healthier growth.

A 31-year-old woman is using Dutasteride (0.5mg daily) and supplements like a multivitamin, Herbadal, pumpkin seed oil, and vitamin D for genetic hair loss, noticing thicker hair but no new growth after one month. She is considering adding minoxidil and is aware of Dutasteride's risks, especially regarding pregnancy.

The conversation is about an 18-year-old experiencing hair loss after using Minoxidil, with suggestions to add Finasteride to improve results. Users advise that Minoxidil alone doesn't address the root cause of hair loss, and combining it with Finasteride may help maintain hair growth.

The user is experiencing increased hair shedding and is concerned about regression despite consistent use of finasteride, minoxidil, and other treatments. The consensus is that this is likely a temporary shedding phase, and adjustments to the dermarolling frequency are suggested.

The user is experiencing increased thinning around the crown after starting topical Minoxidil and is considering switching from Finasteride to Dutasteride. Responses suggest the thinning might be a temporary shedding phase due to the new treatment, and it's advised to continue the current regimen and monitor progress.